Specialised nutrition in head and neck cancer surgery
A randomised Phase I/II trial to investigate the effects of immune-modulating nutritional supplements provided perioperatively to non-malnourished patients undergoing surgery for head and neck cancer on postoperative immune status and inflammation.
Dr Mark Izzard
30 participants
Jun 11, 2007
Interventional
Conditions
Summary
This is a study of specialised nutrition in people having surgery for head and neck cancer. Who is it for? You can join this study if you are undergoing major surgery for head and neck cancer and your doctor thinks you are not malnourished. Trial details Participants will be randomly divided into three groups. The different groups receive either: • preoperatively 5 days of oral IMPACT solution and postoperatively IMPACT enteral feeding. (IMPACT contains a number of supplements that may help the immune system.) • preoperatively 5 days of oral glutamine supplements and postoperative glutamine enteral feeding. (Glutamine may help the immune system.) • standard nutritional supplementation which usually involves no preoperative supplements and standard postoperative enteral feeding. The study looks at the effects of the different regimes. In particular it investigates postoperative immune and inflammatory status measured by blood tests on Days 1, 3, 5 and 7 after surgery. Standard postoperative care for people undergoing major surgery for head and neck cancer includes intensive nursing and medical care and enteral nutritional support. The trial includes different types of supplements which try and help the immune system. One of the trials uses the supplement IMPACT which contains a number of different supplements and the other uses glutamine. The supplements are given orally before the surgery and enterally after the surgery. The blood test results will provide the foundation for a larger scale study with infectious complications and nutritional status as major endpoints.
Eligibility
Plain Language Summary
Simplified for easier understanding
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Three-arm study: IMPACT group receives 5 days standard ORAL IMPACT (Novartis, 3 sachets/d, each sachet of 74g contains 3.8g arginine, 0.4 g nucleotides, 1.0 g eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA)) preoperatively and standard enteral IMPACT postoperatively commencing as soon as possible, within clinical guidelines, after surgery up to full caloric requirements for 5 days. Glutamine group receives 5 days oral lutamine (30g/d, Glutaminox, Oxford Nutrition) preoperatively and glutamine enriched (30g/d) standard enteral feed postoperatively commencing as soon as possible, within clinical guidelines, after surgery up to full caloric requirements for 5 days. .
Locations(1)
View Full Details on ANZCTR
For the most up-to-date information, visit the official listing.
ACTRN12607000162415